The Risk of Upstaged Disease Increases with Body Mass Index in Low-Risk Prostate Cancer Patients Eligible for Active Surveillance-Reference-Cited by-同舟云学术

The Risk of Upstaged Disease Increases with Body Mass Index in Low-Risk Prostate Cancer Patients Eligible for Active Surveillance

Published:2012-02 Issue:2 Volume:61 Page:356-362
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Ploussard Guillaume,de la Taille Alexandre,Bayoud Younes,Durand Xavier,Terry Stéphane,Xylinas Evanguelos,Allory Yves,Vacherot Francis,Abbou Claude-Clément,Salomon Laurent

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Active surveillance for prostate cancer: for whom?;Klotz;J Clin Oncol,2005

2. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience;Tosoian;J Clin Oncol,2011

3. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer;Klotz;J Clin Oncol,2010

4. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly;van den Bergh;Eur Urol,2009

5. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer;Epstein;JAMA,1994

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium;European Urology Oncology;2024-07

2. Cognitive fusion-targeted biopsy versus transrectal ultrasonography-guided systematic biopsy: comparison and analysis of the risk of Gleason score upgrading;International Urology and Nephrology;2023-10-24

3. Chronic Glucocorticoid Use and Risk for Advanced Prostate Cancer at Presentation: A SEER-Medicare Cohort Study;Clinical Genitourinary Cancer;2023-09

4. Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model;International Journal of Molecular Sciences;2023-03-17

5. Feasibility and preliminary clinical tolerability of low‐field MRI‐guided prostate biopsy;The Prostate;2023-02-19